« Publikationen
Phase IIB trial of oral midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3
Fischer, Thomas ; Stone, Richard M. ; DeAngelo, Daniel J. ; Galinsky, Ilene ; Estey, Elihu ; Lanza, Carlo ; Fox, Edward ; Ehninger, Gerhard ; Feldman, Eric J. ; Schiller, Gary J. ; Klimek, Virginia M. ; Nimer, Stephen D. ; Gilliland, D. Gary ; Dutreix, Catherine ; Huntsman-Labed, Alice ; Virkus, Jodi ; Giles, Francis J.
Journal of clinical oncology . - Alexandria, Va. : American Society of Clinical Oncology, Bd. 28.2010, 28, S. 4339-4345
Impact : 17.793
Bibliographie: Originalartikel in begutachteter internationaler Zeitschrift Link 177 Zitationen
Weitere Publikationen der Autoren